Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Non-invasive magnetic resonance imaging follow-up of sono-sensitive liposome tumor delivery and controlled release after high-intensity focused ultrasound.

Fowler RA, Fossheim SL, Mestas JL, Ngo J, Canet-Soulas E, Lafon C.

Ultrasound Med Biol. 2013 Dec;39(12):2342-50. doi: 10.1016/j.ultrasmedbio.2013.06.002.

PMID:
24246245
2.
3.

Magnetic resonance guided high-intensity focused ultrasound mediated hyperthermia improves the intratumoral distribution of temperature-sensitive liposomal doxorubicin.

de Smet M, Hijnen NM, Langereis S, Elevelt A, Heijman E, Dubois L, Lambin P, Grüll H.

Invest Radiol. 2013 Jun;48(6):395-405. doi: 10.1097/RLI.0b013e3182806940.

PMID:
23399809
4.

Stability and trapping of magnetic resonance imaging contrast agents during high-intensity focused ultrasound ablation therapy.

Hijnen NM, Elevelt A, Grüll H.

Invest Radiol. 2013 Jul;48(7):517-24. doi: 10.1097/RLI.0b013e31829aae98.

PMID:
23695082
5.

Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.

Kunimasa J, Inui K, Hori R, Kawamura Y, Endo K.

Chem Pharm Bull (Tokyo). 1992 Sep;40(9):2565-7.

PMID:
1446380
6.

Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging.

Unger EC, Winokur T, MacDougall P, Rosenblum J, Clair M, Gatenby R, Tilcock C.

Radiology. 1989 Apr;171(1):81-5.

PMID:
2928550
7.

Investigation of lanthanide-based starch particles as a model system for liver contrast agents.

Fossheim SL, Kellar KE, Mansson S, Colet JM, Rongved P, Fahlvik AK, Klaveness J.

J Magn Reson Imaging. 1999 Feb;9(2):295-303.

PMID:
10077028
8.

Liposomal Gd-DTPA: preparation and characterization of relaxivity.

Tilcock C, Unger E, Cullis P, MacDougall P.

Radiology. 1989 Apr;171(1):77-80.

PMID:
2928549
9.

Magnetic resonance imaging of brain perfusion using the nonionic contrast agents Dy-DTPA-BMA and Gd-DTPA-BMA.

Kucharczyk J, Asgari H, Mintorovitch J, Vexler Z, Moseley M, Watson A, Rocklage S.

Invest Radiol. 1991 Nov;26 Suppl 1:S250-2; discussion S253-4. No abstract available.

PMID:
1808141
10.

pH-sensitive paramagnetic liposomes as MRI contrast agents: in vitro feasibility studies.

Løkling KE, Fossheim SL, Skurtveit R, Bjørnerud A, Klaveness J.

Magn Reson Imaging. 2001 Jun;19(5):731-8.

PMID:
11672632
11.

Paramagnetic liposomes as magnetic resonance imaging contrast agents. Assessment of contrast efficacy in various liver models.

Fossheim SL, Colet JM, Månsson S, Fahlvik AK, Muller RN, Klaveness J.

Invest Radiol. 1998 Nov;33(11):810-21.

PMID:
9818315
12.

Thermosensitive paramagnetic liposomes for temperature control during MR imaging-guided hyperthermia: in vitro feasibility studies.

Fossheim SL, Il'yasov KA, Hennig J, Bjørnerud A.

Acad Radiol. 2000 Dec;7(12):1107-15.

PMID:
11131055
13.

Gadolinium-DTPA liposomes as a potential MRI contrast agent. Work in progress.

Unger E, Needleman P, Cullis P, Tilcock C.

Invest Radiol. 1988 Dec;23(12):928-32.

PMID:
3203995
14.

Biodistribution and clearance of liposomal gadolinium-DTPA.

Unger E, Cardenas D, Zerella A, Fajardo LL, Tilcock C.

Invest Radiol. 1990 Jun;25(6):638-44.

PMID:
2354925
15.

MR characterization of mild hyperthermia-induced gadodiamide release from thermosensitive liposomes in solid tumors.

Peller M, Schwerdt A, Hossann M, Reinl HM, Wang T, Sourbron S, Ogris M, Lindner LH.

Invest Radiol. 2008 Dec;43(12):877-92. doi: 10.1097/RLI.0b013e31818768cd.

PMID:
19002060
16.

A pharmacokinetic and MRI study of unilamellar gadolinium-, manganese-, and iron-DTPA-stearate liposomes as organ-specific contrast agents.

Schwendener RA, Wüthrich R, Duewell S, Wehrli E, von Schulthess GK.

Invest Radiol. 1990 Aug;25(8):922-32.

PMID:
2394576
17.

Evaluation of two new gadolinium chelates as contrast agents for MRI.

Wiegers CB, Welch MJ, Sharp TL, Brown JJ, Perman WH, Sun Y, Motekaitis RJ, Martell AE.

Magn Reson Imaging. 1992;10(6):903-11.

PMID:
1461088
18.

Combination of gadolinium and dysprosium chelates as a cellular integrity marker in MR imaging.

Ericsson A, Bach-Gansmo T, Niklasson F, Hemmingsson A.

Acta Radiol. 1995 Jan;36(1):41-6.

PMID:
7833167
19.

Comparative evaluation of two membrane-based liposomal MRI contrast agents.

Karlik S, Florio E, Grant CW.

Magn Reson Med. 1991 May;19(1):56-66.

PMID:
2046538
20.

Liposomal Gd-DTPA: effect of encapsulation on enhancement of hepatoma model by MRI.

Unger EC, MacDougall P, Cullis P, Tilcock C.

Magn Reson Imaging. 1989 Jul-Aug;7(4):417-23.

PMID:
2811620

Supplemental Content

Support Center